Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma.
Journal Information
Full Title: J Immunother Cancer
Abbreviation: J Immunother Cancer
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Competing interests: JW is the inventor of the huB10G5 antibody with international patents and the remaining authors declare no potential conflicts of interest."
"Funding: This study was supported by a "Hankookilbo Myung-Ho Seung" Faculty Research Assistance Program of Yonsei University College of Medicine (6-2021-0101), National Research Foundation grant and funded by the Ministry of Science and ICT, Republic of Korea (RS-2023-00208390) and grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI22C1217 and HI22C1826)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025